Playback speed
10 seconds
ESMO GI 2024 Insights: DEEPER Trial - m-FOLFOXIRI + Cetuximab vs. Bevacizumab in Right-Sided/BRAF Mutant mCRC
By
Insights from 2024 ESMO GI Annual Meeting
FEATURING
Yu Sunakawa
By
Insights from 2024 ESMO GI Annual Meeting
FEATURING
Yu Sunakawa
118 views
July 11, 2024
Login to view comments.
Click here to Login